The effects of minidose heparin and low molecular weight heparin on peritonitis in the rat

American Surgeon

Volumn 65, Issue 5, 1999, Pages 473-477

  Vela, A Richard ^a   Littleton, Jeffrey C ^a   O'Leary, J Patrick ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL ABSCESS; ADHESION; ANIMAL MODEL; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; MALE; NONHUMAN; PERITONITIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; TREATMENT OUTCOME;

ABDOMINAL ABSCESS; ADHESIONS; ANIMALS; ENOXAPARIN; HEPARIN; MALE; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS;

EID: 0032902250     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hau T, Ahrenholz DH, Simmons RL. Secondary bacterial peritonitis: The biologic basis of treatment. Curr Probl Surg 1979; 16:1-65.
2. Lehman EP, Boys F. The prevention of peritoneal adhesions with heparin: An experimental study. Ann Surg 1940;111:427-35.
3. Hau T, Simmons RL. Heparin in the treatment of experimental peritonitis. Ann Surg 1978;187:294-8.
4. O'Leary JP, Malik FS, Donahoe RR, Johnston AD. The effects of a minidose of heparin on peritonitis in rats. Surg Gynecol Obstet 1979;148:571-5.
5. O'Leary JP, Packer D, Maples MD, et al. Effect of heparin on the pathophysiology of abdominal adhesion production. In: Lundblad RL, Brown WV, Mann KG, Roberts HR, eds. Chemistry and Biology of Heparin. Amsterdam: Elsevier, 1981, pp 427-34.
6. O'Leary JP, Wickbom G, Cha SO, Wickbom A. The role of feces, necrotic tissue, and various blocking agents in the preven-tion of adhesions. Ann Surg 1988;207:693-8.
7. Chalkiadakis G, Kostakis A, Karayannacos PE, et al. The effect of heparin upon fibrinopurulent peritonitis in rats. Surg Gynecol Obstet 1983;157:257-60.
8. Davidson RK, Cardenas A, Busuttil RW. The effects of heparin and low molecular weight dextran on survival after fibrinopurulent peritonitis. Surg Gynecol Obstet 1981;153:327-31.
9. Lovenox ® Product Information. Collegeville, PA: Rhone-Poulenc Rorer Pharmaceuticals Inc., 1995.
10. Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-9.
11. Leclerc J, Geerts W, Desjardins L, et al. A randomized trial of enoxaparin for the prevention of deep vein thrombosis after major knee surgery. Thromb Haemost 1991;65(Suppl):753.
12. van Goor K, de Graaf JS, Kooi K, et al. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. J Am Coll Surg 1994;179:407-11.
13. van Goor H, de Graaf JS, Grond J, et al. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis. Br J Surg 1994;81:1046-9.
14. Ahrenholz DH, Simmons RL. Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery 1980;88:41-7.
15. Rotstein OD, Pruett TL, Simmons RL. Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes. Ann Surg 1986;203:413-9.
16. Holtz G. Prevention of postoperative adhesions. J Reprod Med 1980;24:141-6.
17. Ninno MA. Pharmacotherapy. Low molecular weight heparin: Pharmacoeconomics. Curr Surg 1996;53:225-30.
18. Filler RM, Sleeman HK, Hendry WS, Pulaski EJ. Lethal factors in experimental peritonitis. Surgery 1966;60:671-8.
19. Hau T, Hoffman R, Simmons RL. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis. Surgery 1978;83:223-9.
20. Zinsser HH, Pryde AW. Experimental study of physical factors, including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog. Ann Surg 1952;136:818-27.